Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ENBIOSIS Biotechnology logo — Inner Voice of Your Body

ENBIOSIS Biotechnology

Inner Voice of Your Body

Founded 2019 United Kingdom London, United Kingdom 23 employees Seed Total: $100.00K Biotechnology

General Information

Company Name ENBIOSIS Biotechnology
Founded Year 2019
Location United Kingdom London, United Kingdom
Employees 23
Industries Biotechnology
Funding Stage Seed
Business Model B2B, SaaS, B2B2C
Revenue Model Subscription, Service Fee, Data Monetization
Social

BounceWatch is an independent company data service, not affiliated with ENBIOSIS Biotechnology. To contact ENBIOSIS Biotechnology, visit enbiosis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ENBIOSIS Biotechnology compare?

A PDF of ENBIOSIS Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ENBIOSIS Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ENBIOSIS Biotechnology

ENBIOSIS Biotechnology, founded in 2019, operates out of the United Kingdom and is making significant strides in the Biotechnology industry. The company’s slogan, "Inner Voice of Your Body," aptly captures its mission to decode the gut microbiome's complexities through advanced big data and AI technologies.

Their core innovation lies in a clinically validated, cloud-based platform that delivers personalized food and supplement recommendations aimed at managing gastrointestinal disorders. This positions ENBIOSIS Biotechnology at the intersection of healthcare and technology, offering scalable SaaS solutions for healthcare providers and partners seeking to enhance service delivery.

The company's growth trajectory received a boost from a $100.00K seed investment by Pragma Corporate Finance on 01 May 2021. This financial backing underscores investor confidence in the company's potential to disrupt the personalized healthcare market with its cutting-edge microbiome analysis solutions.

Business keywords: gut microbiome, big data, personalized nutrition, precision supplements, gastrointestinal disorders, SaaS product, microbiome analysis, personalized medicine, microbiome organisms, scientific inventions, microbiome test, cloud-based technology, clinically proven solutions, healthcare integration

Services & Products

AI-powered nutraceutical formulation
Microbiome interaction modeling
Premixed supplement blends
Targeted health support solutions
Clinical validation of products

Target Customers

Healthcare practitioners Supplement brands Functional food manufacturers Health coaches

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $100.00K 1
Pragma Corporate Finance
01 May 2021

ENBIOSIS Biotechnology Alternatives & Competitors

View All Alternatives
ENBIOSIS Biotechnology vs
DayTwo
DayTwo United States

Precision Nutrition for Metabolic Disease

16 employees
Biotechnology, Health Care
ENBIOSIS Biotechnology vs
Evvy
Evvy United States

Precision women's healthcare, powered by the vaginal microbiome.

Series A
61 employees
Biotechnology, Health Care
ENBIOSIS Biotechnology vs
Tesu Health
Tesu Health United Kingdom

Evidence-based digital therapeutics platform for personalised management of chronic diseases.

3 employees
Biotechnology, Digital Health
View all alternatives

FAQ About ENBIOSIS Biotechnology

Inner Voice of Your Body
ENBIOSIS Biotechnology was founded in 2019.
ENBIOSIS Biotechnology is headquartered in London, United Kingdom.
ENBIOSIS Biotechnology operates in Biotechnology. Its work centres on gut microbiome, big data, personalized nutrition and precision supplements. Its customers include Healthcare practitioners, Supplement brands and Functional food manufacturers.
ENBIOSIS Biotechnology has a B2B, SaaS and B2B2C business model. Its revenue comes from Subscription, Service Fee and Data Monetization.
ENBIOSIS Biotechnology has approximately 23 employees.
ENBIOSIS Biotechnology has completed 1 funding round, raising a total of $100.00K. The latest funding stage is Seed.
ENBIOSIS Biotechnology offers: AI-powered nutraceutical formulation, Microbiome interaction modeling, Premixed supplement blends, Targeted health support solutions, Clinical validation of products.
Top alternatives and competitors to ENBIOSIS Biotechnology include DayTwo, Evvy, Tesu Health, Tiny Health, NutriCare Wellbeing Program. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ENBIOSIS Biotechnology and DayTwo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ENBIOSIS Biotechnology, https://bouncewatch.com/company/enbiosis-biosciences, updated 3 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes